首页> 外国专利> Theophylline and cinnamamide association for asthma - gives prolonged activity, up to 24 hours, and uses some novel cpds. e.g. 3-cinnamoyl 2,2-di:methyl oxazolidine

Theophylline and cinnamamide association for asthma - gives prolonged activity, up to 24 hours, and uses some novel cpds. e.g. 3-cinnamoyl 2,2-di:methyl oxazolidine

机译:茶碱和肉桂酰胺联合治疗哮喘-可延长活动时间(长达24小时),并使用一些新颖的cpds。例如3-肉桂酰基2,2-二:甲基恶唑烷

摘要

Prolonged action medicament contains an association of theophylline (1,3-dimethyl-xanthine) or its derivs. and a cinnamamide of formula (I) or 4-R-Ph-CH=CH-CO-NR1R2 (I) (where R is H, halo or acetyl; R1 is H or methyl; R2 is CHR3-CH2OH; R3 is H or methyl or R1 and R2 together with the N atom are 2,2-dimethyl-3-oxazolidinyl). Cinnamamides of formula (I) are new where a) R is H or halo and -NR1R2 is 2,2-dimethyl-3-oxazolidinyl and b) R is acetyl, R1 is H and R2 is hydroxyethyl. Theophylline is a known bronchodilator used in the treatment of asthma, but is not well tolerated and not very effective. To give best results it would have to be administered every 6 hrs. The association of theophylline with (I) gives prolonged activity (up to 24 hrs.) and may be administered orally, parenterally or rectally. Activity tests are described.
机译:长效药物含有茶碱(1,3-二甲基黄嘌呤)或其衍生物。和式(I)或4-R-Ph-CH = CH-CO-NR1R2(I)的肉桂酰胺(其中R是H,卤素或乙酰基; R1是H或甲基; R2是CHR3-CH2OH; R3是H或甲基或R 1和R 2与N原子一起是2,2-二甲基-3-恶唑烷基。式(I)的肉桂酰胺是新的,其中a)R为H或卤素,-NR 1 R 2为2,2-二甲基-3-恶唑烷基,b)R为乙酰基,R 1为H,R 2为羟乙基。茶碱是一种已知的用于治疗哮喘的支气管扩张剂,但耐受性差且疗效不佳。为了获得最佳效果,必须每6小时进行一次给药。茶碱与(I)的结合可延长活性(长达24小时),可口服,肠胃外或直肠给药。描述了活动测试。

著录项

  • 公开/公告号FR2526317B1

    专利类型

  • 公开/公告日1984-10-05

    原文格式PDF

  • 申请/专利权人 LIPHA;

    申请/专利号FR19820007695

  • 发明设计人

    申请日1982-05-04

  • 分类号A61K31/52;A61K31/16;

  • 国家 FR

  • 入库时间 2022-08-22 08:45:31

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号